Sweetfern Tonic
Natural health product licensed in Canada
- Licence holder
- The Algonquin Tea Company Inc.
- NPN or DIN-HM
- 80080382
- Status
- Active licence
- Licence date
- 2 October 2017
- Revision date
- Not provided
- Form
- Sachet de thé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rubus idaeus Source : Feuille | 55 mg | Not calculated |
| Urtica dioica Source : Feuille | 165 mg | Not calculated |
| Trifolium pratense Source : Feuille et fleur | 55 mg | Not calculated |
| Taraxacum officinale Source : Racine | 25 mg | Not calculated |
| Arctium lappa Source : Racine | 25 mg | Not calculated |
| Rumex crispus Source : Racine | 25 mg | Not calculated |
| Comptonia peregrina Source : Sommité | 650 mg | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 tea bag | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine as a digestive tonic. Traditionally used in Herbal Medicine to alleviate the pain associated with rheumatism. Traditionally used in Herbal Medicine as an alterative to help relieve skin conditions. Traditionally used in Herbal Medicine as an astringent to help relieve diarrhea.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, feet, and face) or are taking products containing diuretics, do not use. Do not use if you are pregnant or breastfeeding. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing.
- Contre-indications
Do not use if you are allergic to plants of the Asteraceae/Compositae/ Daisy family.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use.
Source
Official Health Canada record, licence 80080382
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.